{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:52:04Z","timestamp":1783734724252,"version":"3.55.0"},"reference-count":124,"publisher":"Ubiquity Press, Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,24]]},"DOI":"10.5334\/tohm.661","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T12:23:21Z","timestamp":1637756601000},"source":"Crossref","is-referenced-by-count":17,"title":["Towards Precision Therapies for Inherited Disorders of Neurodegeneration with Brain Iron Accumulation"],"prefix":"10.5334","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4096-6945","authenticated-orcid":false,"given":"Robert V.V.","family":"Spaull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2124-6731","authenticated-orcid":false,"given":"Audrey K.S.","family":"Soo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1328-6311","authenticated-orcid":false,"given":"Penelope","family":"Hogarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2595-3943","authenticated-orcid":false,"given":"Susan J.","family":"Hayflick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3529-5075","authenticated-orcid":false,"given":"Manju A.","family":"Kurian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","reference":[{"key":"key20211124075844_B1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3174\/ajnr.A2677","article-title":"Neuroimaging Features of Neurodegeneration with Brain Iron Accumulation","volume":"33","year":"2012","journal-title":"Am J Neuroradiol"},{"key":"key20211124075844_B2","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1093\/brain\/awaa304","article-title":"KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation","volume":"143","year":"2020","journal-title":"Brain"},{"key":"key20211124075844_B3","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/antiox9101020","article-title":"Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)","volume":"9","year":"2020","journal-title":"Antioxidants"},{"key":"key20211124075844_B4","doi-asserted-by":"crossref","first-page":"fcaa178","DOI":"10.1093\/braincomms\/fcaa178","article-title":"Magnetic resonance imaging pattern recognition in childhood bilateral basal ganglia disorders","volume":"2","year":"2020","journal-title":"Brain Commun"},{"key":"key20211124075844_B5","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ana.25879","article-title":"Loss-of-Function Variants in HOPS Complex Genes VPS16 and VPS41 Cause Early Onset Dystonia Associated with Lysosomal Abnormalities","volume":"88","year":"2020","journal-title":"Ann Neurol"},{"key":"key20211124075844_B6","volume-title":"GeneReviews\u00ae [Internet]","year":"2017"},{"key":"key20211124075844_B7","first-page":"293","volume-title":"Handbook of Clinical Neurology","year":"2018"},{"key":"key20211124075844_B8","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of Intraventricular Cerliponase Alfa for CLN2 Disease","volume":"378","year":"2018","journal-title":"N Engl J Med"},{"key":"key20211124075844_B9","first-page":"2633105520973985","article-title":"The First Orally Deliverable Small Molecule for the Treatment of Spinal Muscular Atrophy","volume":"15","year":"2020","journal-title":"Neurosci Insights"},{"key":"key20211124075844_B10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/brain\/awy331","article-title":"Gene therapy improves motor and mental function of aromatic l-amino acid decarboxylase deficiency","volume":"142","year":"2019","journal-title":"Brain"},{"key":"key20211124075844_B11","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1038\/s41467-021-24524-8","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons","volume":"12","year":"2021","journal-title":"Nat Commun"},{"key":"key20211124075844_B12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jnc.13425","article-title":"Iron neurochemistry in Alzheimer\u2019s disease and Parkinson\u2019s disease: targets for therapeutics","volume":"139","year":"2016","journal-title":"J Neurochem"},{"key":"key20211124075844_B13","first-page":"165","volume-title":"International Review of Neurobiology","year":"2013"},{"key":"key20211124075844_B14","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.neuroimage.2011.08.077","article-title":"MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping","volume":"59","year":"2012","journal-title":"NeuroImage"},{"key":"key20211124075844_B15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2018.09.033","article-title":"Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration","volume":"133","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"key20211124075844_B16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajhg.2018.01.003","article-title":"Impaired Transferrin Receptor Palmitoylation and Recycling in Neurodegeneration with Brain Iron Accumulation","volume":"102","year":"2018","journal-title":"Am J Hum Genet"},{"key":"key20211124075844_B17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","year":"2016","journal-title":"Cell Death Differ"},{"key":"key20211124075844_B18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archneur.1974.00490310072012","article-title":"Hallervorden-Spatz Syndrome","volume":"30","year":"1974","journal-title":"Arch Neurol"},{"key":"key20211124075844_B19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng572","article-title":"A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome","volume":"28","year":"2001","journal-title":"Nat Genet"},{"key":"key20211124075844_B20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa020817","article-title":"Genetic, clinical, and radiographic delineation of Hallervorden\u2013Spatz syndrome","volume":"348","year":"2003","journal-title":"N Engl J Med"},{"key":"key20211124075844_B21","article-title":"4\u2032-Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN","volume":"11","year":"2019","journal-title":"EMBO Mol Med"},{"key":"key20211124075844_B22","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3390\/brainsci11081031","article-title":"Coenzyme a Biochemistry: From Neurodevelopment to Neurodegeneration","volume":"11","year":"2021","journal-title":"Brain Sci"},{"key":"key20211124075844_B23","article-title":"CoA-dependent activation of mitochondrial acyl carrier protein links four neurodegenerative diseases","volume":"11","year":"2019","journal-title":"EMBO Mol Med"},{"key":"key20211124075844_B24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1039\/C3NP70054B","article-title":"The phosphopantetheinyl transferases: catalysis of a post-translational modification crucial for life","volume":"31","year":"2014","journal-title":"Nat Prod Rep"},{"key":"key20211124075844_B25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/bio.2015.0032","article-title":"A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project","volume":"13","year":"2015","journal-title":"Biopreservation Biobanking"},{"key":"key20211124075844_B26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/hmg\/ddg026","article-title":"An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria","volume":"12","year":"2003","journal-title":"Hum Mol Genet"},{"key":"key20211124075844_B27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1196\/annals.1306.023","article-title":"Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration","volume":"1012","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"key20211124075844_B28","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ana.410240519","article-title":"Hallervorden-Spatz syndrome: Clinical and magnetic resonance imaging correlations","volume":"24","year":"1988","journal-title":"Ann Neurol"},{"key":"key20211124075844_B29","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/brain\/awr042","article-title":"Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration","volume":"134","year":"2011","journal-title":"Brain"},{"key":"key20211124075844_B30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1212\/WNL.0b013e31827e07be","article-title":"New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN","volume":"80","year":"2013","journal-title":"Neurology"},{"key":"key20211124075844_B31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ng1826","article-title":"PLA2G, encoding a phospholipase A 2, is mutated in neurodegenerative disorders with high brain iron","volume":"38","year":"2006","journal-title":"Nat Genet"},{"key":"key20211124075844_B32","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.cellsig.2005.03.002","article-title":"Cellular regulation and proposed biological functions of group via calcium-independent phospholipase A2 in activated cells","volume":"17","year":"2005","journal-title":"Cell Signal"},{"key":"key20211124075844_B33","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/brain\/awv132","article-title":"Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction","volume":"138","year":"2015","journal-title":"Brain"},{"key":"key20211124075844_B34","volume-title":"GeneReviews\u00ae [Internet]","year":"2017"},{"key":"key20211124075844_B35","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.neurobiolaging.2010.05.009","article-title":"Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations","volume":"33","year":"2012","journal-title":"Neurobiol Aging"},{"key":"key20211124075844_B36","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/01.wnl.0000327094.67726.28","article-title":"Neurodegeneration associated with genetic defects in phospholipase A2","volume":"71","year":"2008","journal-title":"Neurology"},{"key":"key20211124075844_B37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ajhg.2011.09.007","article-title":"Absence of an Orphan Mitochondrial Protein, C19orf12, Causes a Distinct Clinical Subtype of Neurodegeneration with Brain Iron Accumulation","volume":"89","year":"2011","journal-title":"Am J Hum Genet"},{"key":"key20211124075844_B38","article-title":"Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN)","volume":"7","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"key20211124075844_B39","first-page":"185","article-title":"Mutations of C19orf12, coding for a transmembrane glycine zipper containing mitochondrial protein, cause mis-localization of the protein, inability to respond to oxidative stress and increased mitochondrial Ca2+","volume":"6","year":"2015","journal-title":"Front Genet"},{"key":"key20211124075844_B40","volume-title":"GeneReviews\u00ae [Internet]","year":"2021"},{"key":"key20211124075844_B41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.parkreldis.2017.03.012","article-title":"The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN","volume":"39","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"key20211124075844_B42","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.ajhg.2012.10.019","article-title":"Exome Sequencing Reveals De Novo WDR45 Mutations Causing a Phenotypically Distinct, X-Linked Dominant Form of NBIA","volume":"91","year":"2012","journal-title":"Am J Hum Genet"},{"key":"key20211124075844_B43","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ng.2562","article-title":"De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood","volume":"45","year":"2013","journal-title":"Nat Genet"},{"key":"key20211124075844_B44","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1093\/brain\/awy230","article-title":"Iron overload is accompanied by mitochondrial and lysosomal dysfunction in WDR45 mutant cells","volume":"141","year":"2018","journal-title":"Brain"},{"key":"key20211124075844_B45","doi-asserted-by":"crossref","first-page":"645831","DOI":"10.3389\/fmolb.2021.645831","article-title":"WDR45 Mutation Impairs the Autophagic Degradation of Transferrin Receptor and Promotes Ferroptosis","volume":"8","year":"2021","journal-title":"Front Mol Biosci"},{"key":"key20211124075844_B46","article-title":"Consensus clinical management guideline for beta-propeller protein-associated neurodegeneration","journal-title":"Dev Med Child Neurol"},{"key":"key20211124075844_B47","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/brain\/awt095","article-title":"Beta-propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation","volume":"136","year":"2013","journal-title":"Brain"},{"key":"key20211124075844_B48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40478-015-0221-3","article-title":"Neuropathology of Beta-propeller protein associated neurodegeneration (BPAN): a new tauopathy","volume":"3","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"key20211124075844_B49","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.22947","article-title":"ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation","volume":"25","year":"2010","journal-title":"Mov Disord"},{"key":"key20211124075844_B50","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1007\/s00018-020-03747-w","article-title":"Pathogenic mechanism and modeling of neuroferritinopathy","volume":"78","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"key20211124075844_B51","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ng571","article-title":"Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease","volume":"28","year":"2001","journal-title":"Nat Genet"},{"key":"key20211124075844_B52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4471-6455-5_11","volume-title":"Chorea: Causes and Management","year":"2014"},{"key":"key20211124075844_B53","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ajhg.2008.10.018","article-title":"Mutations in C2orf37, Encoding a Nucleolar Protein, Cause Hypogonadism, Alopecia, Diabetes Mellitus, Mental Retardation, and Extrapyramidal Syndrome","volume":"83","year":"2008","journal-title":"Am J Hum Genet"},{"key":"key20211124075844_B54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajhg.2013.11.008","article-title":"Exome Sequence Reveals Mutations in CoA Synthase as a Cause of Neurodegeneration with Brain Iron Accumulation","volume":"94","year":"2014","journal-title":"Am J Hum Genet"},{"key":"key20211124075844_B55","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/ajmg.a.38252","article-title":"Diagnosis of CoPAN by whole exome sequencing: Waking up a sleeping tiger\u2019s eye","volume":"173","year":"2017","journal-title":"Am J Med Genet A"},{"key":"key20211124075844_B56","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1212\/WNL.0000000000002157","article-title":"SCP2 mutations and neurodegeneration with brain iron accumulation","volume":"85","year":"2015","journal-title":"Neurology"},{"key":"key20211124075844_B57","first-page":"216","article-title":"Identification of mutation in GTPBP2 in patients of a family with neurodegeneration accompanied by iron deposition in the brain","volume":"38","year":"2016","journal-title":"Neurobiol Aging"},{"key":"key20211124075844_B58","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41431-018-0097-3","article-title":"Biallelic inactivating variants in the GTPBP2 gene cause a neurodevelopmental disorder with severe intellectual disability","volume":"26","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"key20211124075844_B59","article-title":"AP4 deficiency: A novel form of neurodegeneration with brain iron accumulation?","volume":"4","year":"2018","journal-title":"Neurol Genet"},{"key":"key20211124075844_B60","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fnins.2019.00180","article-title":"Iron in Neurodegeneration \u2013 Cause or Consequence?","volume":"13","year":"2019","journal-title":"Front Neurosci"},{"key":"key20211124075844_B61","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMra1800219","article-title":"The Role of Deferiprone in Iron Chelation","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"key":"key20211124075844_B62","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3324\/haematol.2011.043018","article-title":"A pilot trial of deferiprone for neurodegeneration with brain iron accumulation","volume":"96","year":"2011","journal-title":"Haematologica"},{"key":"key20211124075844_B63","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mds.22002","article-title":"Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation","volume":"23","year":"2008","journal-title":"Mov Disord"},{"key":"key20211124075844_B64","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.parkreldis.2011.06.024","article-title":"Long-term improvement under deferiprone in a case of neurodegeneration with brain iron accumulation","volume":"18","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"key20211124075844_B65","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fneur.2017.00385","article-title":"Patient Affected by Beta-Propeller Protein-Associated Neurodegeneration: A Therapeutic Attempt with Iron Chelation Therapy","volume":"8","year":"2017","journal-title":"Front Neurol"},{"key":"key20211124075844_B66","doi-asserted-by":"crossref","first-page":"89","DOI":"10.14802\/jmd.17082","article-title":"A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy","volume":"11","year":"2018","journal-title":"J Mov Disord"},{"key":"key20211124075844_B67","first-page":"1756","article-title":"Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial","volume":"26","year":"2011","journal-title":"Mov Disord"},{"key":"key20211124075844_B68","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.parkreldis.2014.03.002","article-title":"Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up","volume":"20","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"key20211124075844_B69","first-page":"7279","article-title":"A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients","volume":"9","year":"2017","journal-title":"Neurol Int"},{"key":"key20211124075844_B70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13023-020-01385-w","article-title":"Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports","volume":"15","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"key20211124075844_B71","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1474-4422(19)30142-5","article-title":"Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"key":"key20211124075844_B72","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1750-1172-7-66","article-title":"An international registry for neurodegeneration with brain iron accumulation","volume":"7","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"key20211124075844_B73","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/ana.20457","article-title":"Pallidal stimulation improves pantothenate kinase\u2013associated neurodegeneration","volume":"57","year":"2005","journal-title":"Ann Neurol"},{"key":"key20211124075844_B74","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejpn.2008.01.006","article-title":"Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration","volume":"13","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"key":"key20211124075844_B75","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awq022","article-title":"Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation","volume":"133","year":"2010","journal-title":"Brain"},{"key":"key20211124075844_B76","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/dmcn.12117","article-title":"Proportion of life lived with dystonia inversely correlates with response to pallidal deep brain stimulation in both primary and secondary childhood dystonia","volume":"55","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"key20211124075844_B77","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/jnnp-2019-322169","article-title":"Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis","volume":"91","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20211124075844_B78","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/mdc3.12030","article-title":"Atypical PLA2G6-Associated Neurodegeneration: Social Communication Impairment, Dystonia and Response to Deep Brain Stimulation","volume":"1","year":"2014","journal-title":"Mov Disord Clin Pract"},{"key":"key20211124075844_B79","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3171\/jns.1999.90.3.0551","article-title":"Stereotactic pallidotomy in a child with Hallervorden\u2014Spatz disease: Case report","volume":"90","year":"1999","journal-title":"J Neurosurg"},{"key":"key20211124075844_B80","first-page":"197","article-title":"Deep brain stimulation versus pallidotomy for status dystonicus: a single-center case series","volume":"134","year":"2019","journal-title":"J Neurosurg"},{"key":"key20211124075844_B81","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00008506-200004000-00006","article-title":"Anesthetic Management For Two-Stage Computer-Assisted, Stereotactic Thalamotomy in a Child With Hallervorden-Spatz Disease","volume":"12","year":"2000","journal-title":"J Neurosurg Anesthesiol"},{"key":"key20211124075844_B82","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0387-7604(12)80246-4","article-title":"A case of Hallervorden-Spatz disease: Progressive and intractable dystonia controlled by bilateral thalamotomy","volume":"14","year":"1992","journal-title":"Brain Dev"},{"key":"key20211124075844_B83","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/mds.20655","article-title":"Staged bilateral stereotactic pallidothalamotomy for life-threatening dystonia in a child with Hallervorden\u2013Spatz disease","volume":"21","year":"2006","journal-title":"Mov Disord"},{"key":"key20211124075844_B84","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/mds.28384","article-title":"Bilateral Pallidotomy for Dystonia: A Systematic Review","volume":"36","year":"2021","journal-title":"Mov Disord"},{"key":"key20211124075844_B85","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ymgme.2016.11.004","article-title":"Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN)","volume":"120","year":"2017","journal-title":"Mol Genet Metab"},{"key":"key20211124075844_B86","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/00006123-199605000-00015","article-title":"Continuous intrathecal baclofen infusion for symptomatic generalized dystonia","volume":"38","year":"1996","journal-title":"Neurosurgery"},{"key":"key20211124075844_B87","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.clinph.2003.11.008","article-title":"Electrophysiological assessment of the effect of intrathecal baclofen in dystonic children","volume":"115","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"key20211124075844_B88","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/02688690701392899","article-title":"The role of intrathecal baclofen in the management of primary and secondary dystonia in children","volume":"21","year":"2007","journal-title":"Br J Neurosurg"},{"key":"key20211124075844_B89","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/PHM.0b013e318282d209","article-title":"Treatment of classic pantothenate kinase-associated neurodegeneration with deferiprone and intrathecal baclofen","volume":"92","year":"2013","journal-title":"Am J Phys Med Rehabil"},{"key":"key20211124075844_B90","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3171\/2008.10.PEDS0847","article-title":"Intraventricular baclofen for dystonia: techniques and outcomes: Clinical article","volume":"3","year":"2009","journal-title":"J Neurosurg Pediatr"},{"key":"key20211124075844_B91","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000052146","article-title":"Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome","volume":"45","year":"2001","journal-title":"Eur Neurol"},{"key":"key20211124075844_B92","article-title":"Efficacy of botulinum toxin A treatment in a case of pantothenate kinase associated neurodegeneration (PKAN)","year":"2011","journal-title":"BMJ Case Rep"},{"key":"key20211124075844_B93","article-title":"Botulinum toxin injection to improve functional independence and to alleviate parenting stress in a child with advanced pantothenate kinase-associated neurodegeneration","volume":"97","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"key20211124075844_B94","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10072-019-04099-5","article-title":"Palliative care in 9 children with neurodegeneration with brain iron accumulation","volume":"41","year":"2020","journal-title":"Neurol Sci"},{"key":"key20211124075844_B95","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000370005","article-title":"Intrathecal morphine therapy in the management of status dystonicus in neurodegeneration brain iron accumulation type 1","volume":"50","year":"2015","journal-title":"Pediatr Neurosurg"},{"key":"key20211124075844_B96","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1038\/s41467-018-06703-2","article-title":"A therapeutic approach to pantothenate kinase associated neurodegeneration","volume":"9","year":"2018","journal-title":"Nat Commun"},{"key":"key20211124075844_B97","article-title":"Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models","volume":"13","year":"2018","journal-title":"PLOS ONE"},{"key":"key20211124075844_B98","first-page":"3247034","article-title":"Open-Label Fosmetpantotenate, a Phosphopantothenate Replacement Therapy in a Single Patient with Atypical PKAN","year":"2017","journal-title":"Case Rep Neurol Med"},{"key":"key20211124075844_B99","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/mds.28392","article-title":"Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase-Associated Neurodegeneration","volume":"36","year":"2021","journal-title":"Mov Disord"},{"key":"key20211124075844_B100","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.1073\/pnas.0912105107","article-title":"Pantethine rescues a Drosophila model for pantothenate kinase\u2013associated neurodegeneration","volume":"107","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"key20211124075844_B101","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2015.10.010","article-title":"Knock-down of pantothenate kinase 2 severely affects the development of the nervous and vascular system in zebrafish, providing new insights into PKAN disease","volume":"85","year":"2016","journal-title":"Neurobiol Dis"},{"key":"key20211124075844_B102","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/brain\/awt325","article-title":"Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model","volume":"137","year":"2014","journal-title":"Brain"},{"key":"key20211124075844_B103","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s13023-020-01530-5","article-title":"Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study","volume":"15","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"key20211124075844_B104","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nchembio.1906","article-title":"Extracellular 4\u2032-phosphopantetheine is a source for intracellular coenzyme A synthesis","volume":"11","year":"2015","journal-title":"Nat Chem Biol"},{"key":"key20211124075844_B105","doi-asserted-by":"crossref","first-page":"15785","DOI":"10.1021\/acs.jmedchem.0c01531","article-title":"Cyclic Phosphopantothenic Acid Prodrugs for Treatment of Pantothenate Kinase-Associated Neurodegeneration","volume":"63","year":"2020","journal-title":"J Med Chem"},{"key":"key20211124075844_B106","doi-asserted-by":"crossref","first-page":"11260","DOI":"10.1038\/s41598-017-11564-8","article-title":"Acetyl-4\u2032-phosphopantetheine is stable in serum and prevents phenotypes induced by pantothenate kinase deficiency","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"key20211124075844_B107","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.15252\/emmm.201606391","article-title":"Coenzyme A corrects pathological defects in human neurons of PANK2-associated neurodegeneration","volume":"8","year":"2016","journal-title":"EMBO Mol Med"},{"key":"key20211124075844_B108","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jmd2.12116","article-title":"Treatment of infantile neuroaxonal dystrophy with RT001: A di-deuterated ethyl ester of linoleic acid: Report of two cases","volume":"54","year":"2020","journal-title":"JIMD Rep"},{"key":"key20211124075844_B109","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cmet.2018.05.019","article-title":"Phospholipase PLA2G6, a Parkinsonism-Associated Gene, Affects Vps26 and Vps35, Retromer Function, and Ceramide Levels, Similar to \u03b1-Synuclein Gain","volume":"28","year":"2018","journal-title":"Cell Metab"},{"key":"key20211124075844_B110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/15548627.2019.1630224","article-title":"WDR45 contributes to neurodegeneration through regulation of ER homeostasis and neuronal death","volume":"16","year":"2020","journal-title":"Autophagy"},{"key":"key20211124075844_B111","doi-asserted-by":"crossref","first-page":"91","DOI":"10.15252\/emmm.201708361","article-title":"Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia","volume":"10","year":"2018","journal-title":"EMBO Mol Med"},{"key":"key20211124075844_B112","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.braindev.2007.01.001","article-title":"Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate","volume":"29","year":"2007","journal-title":"Brain Dev"},{"key":"key20211124075844_B113","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJMoa1813279","article-title":"Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease","volume":"381","year":"2019","journal-title":"N Engl J Med"},{"key":"key20211124075844_B114","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"key20211124075844_B115","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","volume":"377","year":"2017","journal-title":"N Engl J Med"},{"key":"key20211124075844_B116","first-page":"S308","article-title":"Gene therapy for AADC Deficiency","volume":"84","year":"2018","journal-title":"Ann Neurol"},{"key":"key20211124075844_B117","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","year":"2019","journal-title":"Nature"},{"key":"key20211124075844_B118","unstructured":"Whaler S. Novel Strategies in NBIA: A Gene Therapy Approach for PLA2G6-Associated Neurodegeneration. Dr. Thesis UCL Univ. Coll. Lond. 2018; 1\u2013280."},{"key":"key20211124075844_B119","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1093\/hmg\/dds380","article-title":"Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model","volume":"21","year":"2012","journal-title":"Hum Mol Genet"},{"key":"key20211124075844_B120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00438-020-01742-1","article-title":"Compound heterozygous PLA2G6 loss-of-function variants in Swaledale sheep with neuroaxonal dystrophy","volume":"296","year":"2021","journal-title":"Mol Genet Genomics"},{"key":"key20211124075844_B121","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41434-020-0178-0","article-title":"Transduction patterns in the CNS following various routes of AAV-5-mediated gene delivery","volume":"28","year":"2021","journal-title":"Gene Ther"},{"key":"key20211124075844_B122","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ymthe.2019.11.012","article-title":"A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna","volume":"28","year":"2020","journal-title":"Mol Ther"},{"key":"key20211124075844_B123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14802\/jmd.14034","article-title":"Neurodegeneration with Brain Iron Accumulation: Diagnosis and Management","volume":"8","year":"2015","journal-title":"J Mov Disord"},{"key":"key20211124075844_B124","volume-title":"GeneReviews\u00ae","year":"2019"}],"container-title":["Tremor and Other Hyperkinetic Movements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/doi.org\/10.5334\/tohm.661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T02:04:21Z","timestamp":1699841061000},"score":1,"resource":{"primary":{"URL":"https:\/\/tremorjournal.org\/articles\/10.5334\/tohm.661\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":124,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,11,24]]}},"alternative-id":["10.5334\/tohm.661"],"URL":"https:\/\/doi.org\/10.5334\/tohm.661","relation":{},"ISSN":["2160-8288"],"issn-type":[{"value":"2160-8288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"51"}}